ADVERTISEMENT

Pharma, Healthcare Q2 Earnings Preview: Improved Margin In Most Cases With Few Exceptions: Yes Securities

The brokerage reckons Ajanta, JB Chemical and Torrent Pharma could report better than expected numbers while Syngene and Gland could display weaker set of earnings.

<div class="paragraphs"><p>Colourful capsules arranged for photograph. (Source: pxhere.com)</p></div>
Colourful capsules arranged for photograph. (Source: pxhere.com)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit